BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16518477)

  • 1. [Molecular biology of CLL].
    Szepesi A
    Magy Onkol; 2005; 49(4):327-30. PubMed ID: 16518477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.
    Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL
    Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
    Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
    J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia.
    Corcoran M; Parker A; Orchard J; Davis Z; Wirtz M; Schmitz OJ; Oscier D
    Haematologica; 2005 Aug; 90(8):1078-88. PubMed ID: 16079107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance of ZAP-70 in patients with chronic lymphocytic leukemia.
    Chaar BT; Schergen AK; Grosso LE
    Int J Lab Hematol; 2008 Feb; 30(1):36-40. PubMed ID: 18190465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Progression--ZAP-70 in CLL.
    Hamblin TJ
    N Engl J Med; 2004 Aug; 351(9):856-7. PubMed ID: 15329421
    [No Abstract]   [Full Text] [Related]  

  • 15. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
    McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
    Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP70 in chronic lymphocytic leukaemia.
    Amin S; Parker A; Mann J
    Int J Biochem Cell Biol; 2008; 40(9):1654-8. PubMed ID: 17625948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic lesions in chronic lymphocytic leukemia: clinical implications.
    Montserrat E; Moreno C
    Curr Opin Oncol; 2009 Nov; 21(6):609-14. PubMed ID: 19713841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocytes in humans express ZAP-70 when activated in vivo.
    Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
    Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.